Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
SCScinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI)

NASDAQ Capital Market · Currency in USD
$0.56 ▼ -0.05 (-7.60%)
At close: Oct 23, 4:00 PM ET. Market closed.
$0.55 ▼ -0.01 (-2.57%)
After hours: Oct 23, 7:59 PM ET

Summary

Previous Close
$0.61
Open
$0.58
Day's Range
$0.55 – $0.59
52 Week Range
$0.55 – $15.50
Volume
36,921
Avg. Volume
1,658,387
Market Cap
$291.81K
Beta (5Y Monthly)
2.13
PE Ratio (TTM)
--
EPS (TTM)
-$0.05
Earnings Date
Dec 2, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Scinai Immunotherapeutics Ltd.

Sector
Healthcare
Industry
Biotechnology
Full-time employees
45
CEO
Amir Reichman
Website
scinai.com

Scinai Immunotherapeutics Ltd. operates as an emerging biopharmaceutical company, dedicated to the research, production, and market introduction of medical solutions. Based in Israel, its primary objective is the prevention and treatment of a range of infectious, autoimmune, and other health conditions. The company maintains a significant licensing and collaboration agreement with the Max Planck Society and the University Medical Center Göttingen.

Earnings

Next report: Wed, Dec 2, 2026
EPS estimate -$8.50 · Revenue est. $494.55K
DateEst.Actual
Aug 24, 2026–-$0.74
Jun 10, 2026–$9.40
Nov 2, 2025–-$35.70
Sep 2, 2025–-$1.20
May 7, 2025–-$10.40
Nov 22, 2024–$8.40

Get free alerts on SCNI and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.